{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:09:33Z","timestamp":1790388573679,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"vor","delay-in-days":349,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.det.2015.05.014","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T01:28:26Z","timestamp":1438219706000},"page":"807-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Hematopoietic Stem Cell Transplant for Mycosis Fungoides and S\u00e9zary Syndrome"],"prefix":"10.1016","volume":"33","author":[{"given":"Pooja","family":"Virmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Zain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Myskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.det.2015.05.014_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.det.2015.05.014_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2015.05.014_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"1102","author":"Kim","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.det.2015.05.014_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2010.08.037","article-title":"S\u00e9zary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)","volume":"64","author":"Olsen","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2015.05.014_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ajh.23756","article-title":"Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Wilcox","year":"2014","journal-title":"Am J Hematol"},{"issue":"31","key":"10.1016\/j.det.2015.05.014_bib6","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised international society for cutaneous lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.det.2015.05.014_bib7","unstructured":"Pasquini MC, Zhu X. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides. 2014. Available at: http:\/\/www.cibmtr.org. Accessed March 25, 2015."},{"key":"10.1016\/j.det.2015.05.014_bib8","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","article-title":"Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)","volume":"85","author":"Schmitz","year":"1995","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.det.2015.05.014_bib9","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2165\/11206040-000000000-00000","article-title":"Plerixafor: a review of its use in stem cell mobilization in patients with Lymphoma or Multiple Myeloma","volume":"71","author":"Keating","year":"2011","journal-title":"Drugs"},{"issue":"16","key":"10.1016\/j.det.2015.05.014_bib10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Worldwide network of blood and marrow transplantation. Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"issue":"Suppl\u00a01","key":"10.1016\/j.det.2015.05.014_bib11","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/bmt.2008.117","article-title":"Haploidentical hematopoietic cell transplantation","volume":"42","author":"Koh","year":"2008","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.det.2015.05.014_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood-2014-02-514760","article-title":"Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist","volume":"124","author":"Kekre","year":"2014","journal-title":"Blood"},{"issue":"88","key":"10.1016\/j.det.2015.05.014_bib13","first-page":"159","article-title":"Recent advances in haploidentical stem cell transplantation","volume":"16","author":"Alpdogan","year":"2013","journal-title":"Discov Med"},{"issue":"10","key":"10.1016\/j.det.2015.05.014_bib14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bbmt.2014.05.015","article-title":"Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies","volume":"20","author":"Eapen","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.det.2015.05.014_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bmt.2014.312","article-title":"Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants","volume":"50","author":"Passweg","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.det.2015.05.014_bib16","article-title":"Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre study","author":"Baronciani","year":"2015","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.det.2015.05.014_bib17","series-title":"Thomas' hematopoietic cell transplantation: stem cell transplantation","article-title":"High-dose preparatory regimens","author":"Bensinger","year":"2009"},{"issue":"29","key":"10.1016\/j.det.2015.05.014_bib18","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1200\/JCO.2014.57.5597","article-title":"Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and S\u00e9zary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis","volume":"32","author":"Duarte","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.det.2015.05.014_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cncr.29163","article-title":"Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the acute leukemia working party of the European Group for Blood and Marrow Transplantation","volume":"121","author":"Baron","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.det.2015.05.014_bib20","first-page":"277","article-title":"Reduced-intensity allogeneic stem cell transplantation","volume":"2","author":"Bearman","year":"2003","journal-title":"Curr Hematol Rep"},{"issue":"8","key":"10.1016\/j.det.2015.05.014_bib21","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/bmt.2010.94","article-title":"How we approach patient evaluation for hematopoietic stem cell transplantation","volume":"45","author":"Hamadani","year":"2010","journal-title":"Bone Marrow Transpl"},{"issue":"9674","key":"10.1016\/j.det.2015.05.014_bib22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.det.2015.05.014_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.det.2015.05.014_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/bmt.2009.275","article-title":"A\u00a0modified comorbidity index for hematopoietic cell transplantation","volume":"45","author":"Defor","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"4993","key":"10.1016\/j.det.2015.05.014_bib25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/bmj.2.4993.626","article-title":"Treatment of murine leukemia with X rays and homologous bone marrow; preliminary communication","volume":"2","author":"Barnes","year":"1956","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.det.2015.05.014_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","article-title":"Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation","volume":"77","author":"Jones","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.det.2015.05.014_bib27","first-page":"133","article-title":"Autologous bone marrow transplantation for advanced stage mycosis fungoides","volume":"7","author":"Bigler","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.det.2015.05.014_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2230.1995.tb01291.x","article-title":"Erythrodermic mycosis fungoides treated with total body irradiation and autologous bone marrow transplantation","volume":"20","author":"Sterling","year":"1995","journal-title":"Clin Exper Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.05.014_bib29","first-page":"1188","article-title":"Autologous haematopoietic progenitor transplantation in advanced mycosis fungoides","volume":"140","author":"FerraFerr\u00e0","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.05.014_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1749-6632.2001.tb03718.x","article-title":"Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: predictors of disease-free survival","volume":"941","author":"Russell-Jones","year":"2001","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"10.1016\/j.det.2015.05.014_bib31","first-page":"304","article-title":"Autologous bone marrow transplantation after supralethal dose of total body irradiation in a case of mycosis fungoides","volume":"85","author":"Chen","year":"1986","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.det.2015.05.014_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1704411","article-title":"High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma","volume":"33","author":"Ingen-Housz-Oro","year":"2004","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.det.2015.05.014_bib33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1365-2141.2001.02919.x","article-title":"T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement","volume":"114","author":"Olavarria","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.det.2015.05.014_bib34","first-page":"775","article-title":"Autologous bone marrow transplantation using TBI and CBV for disseminated high\/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma","volume":"14","author":"Moreau","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.det.2015.05.014_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2340\/0001555574333","article-title":"Mycosis fungoides and allogenic bone marrow transplantation","volume":"74","author":"Koeppel","year":"1994","journal-title":"Acta Derm Venereol"},{"issue":"25","key":"10.1016\/j.det.2015.05.014_bib36","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1200\/JCO.2005.02.774","article-title":"Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides","volume":"23","author":"Molina","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.det.2015.05.014_bib37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbmt.2009.04.017","article-title":"A\u00a0meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and S\u00e9zary syndrome","volume":"15","author":"Wu","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"14","key":"10.1016\/j.det.2015.05.014_bib38","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.2009.25.8301","article-title":"Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome","volume":"28","author":"Duvic","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.det.2015.05.014_bib39","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/bmt.2011.201","article-title":"Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas","volume":"47","author":"Paralkar","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.det.2015.05.014_bib40","article-title":"Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome","author":"Shiratori","year":"2014","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.det.2015.05.014_bib41","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.clml.2014.09.013","article-title":"Long-term complete responses to combination therapies and allogeneic stem cell transplants in patients with S\u00e9zary syndrome","volume":"15","author":"Polansky","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1016\/j.det.2015.05.014_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3324\/haematol.2013.098145","article-title":"Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas","volume":"99","author":"de Masson","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.det.2015.05.014_bib43","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/bmt.2014.161","article-title":"Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome","volume":"49","author":"Lechowicz","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.det.2015.05.014_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.bmt.1704641","article-title":"Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation","volume":"34","author":"Herbert","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.det.2015.05.014_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1705741","article-title":"Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides","volume":"40","author":"Gabriel","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.det.2015.05.014_bib46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.bmt.1705968","article-title":"Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma","volume":"41","author":"Duarte","year":"2008","journal-title":"Bone Marrow Transpl"},{"issue":"18","key":"10.1016\/j.det.2015.05.014_bib47","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.det.2015.05.014_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mgg3.121","article-title":"Personalized treatment of Sezary syndrome by targeting a novel CTLA4:Cd28 fusion","volume":"3","author":"Sekulic","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.det.2015.05.014_bib49","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1111\/j.1440-0960.2012.00944.x","article-title":"Successful treatment of syringotropic CD8+ mycosis fungoides accompanied by hypohidrosis with vorinostat and retinoids","volume":"54","author":"Kakizaki","year":"2013","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.05.014_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3816\/CLM.2009.n.082","article-title":"Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma","volume":"9","author":"Duvic","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"12","key":"10.1016\/j.det.2015.05.014_bib51","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2217\/fon.13.220","article-title":"Romidepsin for cutaneous T-cell lymphoma","volume":"9","author":"Prince","year":"2013","journal-title":"Future Oncol"},{"key":"10.1016\/j.det.2015.05.014_bib52","first-page":"75","article-title":"Management of cutaneous T cell lymphoma: new and emerging targets and treatment options","volume":"4","author":"Li","year":"2012","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.det.2015.05.014_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamadermatol.2014.1629","article-title":"Brentuximab as a treatment for CD30+ mycosis fungoides and S\u00e9zary syndrome","volume":"151","author":"Mehra","year":"2015","journal-title":"JAMA Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T17:04:05Z","timestamp":1691859845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863515000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0733863515000595"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2015.05.014","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Stem Cell Transplant for Mycosis Fungoides and S\u00e9zary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2015.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}